share_log

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $6 Price Target

HC Wainwright & Co. Reiterates Buy on Affimed, Maintains $6 Price Target

HC Wainwright & Co.重申买入 Affimed,维持6美元的目标价
Benzinga ·  2023/05/24 10:27

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:AFMD) with a Buy and maintains $6 price target.

HC Wainwright & Co. 分析师Swayampakula Ramakanth重申Affimed(纳斯达克股票代码:AFMD)的买入,并维持6美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发